VF
FTH

Virtu Financial’s Faeth Therapeutics FTH Stock Holding History

Virtu Financial’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,303
Closed -$39K – 2060
2022
Q4 		$39K Buy
+1,303
New +$38.3K 0.01% 1125
2022
Q3 		– Sell
-561
Closed -$25K – 2205
2022
Q2 		$25K Buy
+561
New +$21K ﹤0.01% 1288
2022
Q1 		– Sell
-799
Closed -$93K – 1993
2021
Q4 		$93K Buy
+799
New +$119K 0.01% 1162

Other funds holding FTH

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's FTH Position: Q1 2023 in Review

Virtu Financial sold out of Faeth Therapeutics (FTH) in Q1 2023, closing a stake of 1,303 shares — an estimated $39K sold.

Virtu Financial first reported a position in FTH in Q4 2021 and held it in 3 quarters. The position peaked at $93K in Q4 2021. 26 funds tracked by Wall St. Rank hold FTH as of Q1 2023.

  • Virtu Financial reported no remaining Faeth Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 1,303 Faeth Therapeutics shares in Q1 2023, an estimated $39K.
  • Virtu Financial first reported a position in Faeth Therapeutics in Q4 2021 and held it in 3 quarters.
  • Virtu Financial's Faeth Therapeutics position peaked at $93K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.